xenon-pharma.com (XENE) - Company Profit
Xenon Pharmaceuticals (XENE) adheres to standard eco-protocols in its laboratories, focusing on therapeutic efficacy. The company develops targeted treatments for epilepsy by modulating brain ion channels. The company's net income dynamics are based on the implementation of AI screening to accelerate drug development, and its latest figure stands at -0.40.
Analytical breakdowns and data insights for company Xenon (XENE)
- stock value and consensus price forecast:
- market capitalization indicators:
- book capitalization information:
- debt burden and liquidity indicators:
Debt to Capital Xenon Pharmaceuticals|XENE - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Xenon Pharmaceuticals Inc.|XENE - Company Total Debt|Debt to Net Assets Ratio Xenon Corp|XENE - Company Long-Term Debt|Current Liabilities Xenon Pharmaceuticals|Intermediate Coverage Ratio xenon-pharma.com
- company profitability and valuation multiples indicators:
Summary company analysis:Xenon Corp (XENE)
Sustainable profit growth demonstrates the long-term viability of the issuer, measuring the net financial remainder after deducting all operating and tax expenses. Analyzing the monetary results of Xenon Pharmaceuticals (XENE) allows for tracking the efficiency of R&D expenditures, as returns in the biotechnology sector correlate not with market cycles, but with the successful completion of clinical trial stages for new drugs.
Main competitors
Company Net Income Biogen Idec (BIIB)|Net Income NBIX|Company Profit RGC (regencellbioscience.com)|Net Profit AXSM|ACAD - Company Net Income|Company Net Income Viking Pharma VKTX|SUPN: Company Profit|CPRX - Company Net Income|Company Net Income denalitherapeutics.com|Harmony Biosciences Holdings, Inc. (HRMY) - Company Net Income|Company Profit BHVN|Net Income AMLX|TRVI: Final Profit|Company Net Income Praxis Precision Medicines (PRAX)|AVXL: Profit After Tax|Net Profit CBLL (CeriBell)|Final Profit PRTA|Alector Therapeutics - Net Profit|ANNX - Net Profit|omeros.com (OMER) - Company Net Income|neurogene.com - Final Profit|Company Net Income AC Immune SA|Net Income Voyager Therapeutics Inc (VYGR)|Net Profit NMRA|Net Profit Scilex Holding Company, Inc. (SCLX)|Net Profit TVGN (Tevogen Bio Holdings)|ACOG - Net Income|Cognition Therapeutics - Net Profit|Company Net Income Inhibikase Therapeutics Inc|SAVA (Cassava) - Net Income|Assertio (ASRT) - Net Profit|Net Income COYA|VTGN (VistaGen Therapeutics Inc) - Profit After Payment of Taxes|Net Profit OVID|Net Financial Result Acumen Pharmaceuticals Inc.|Net Profit CRVO (CervoMed Inc)|ATHE - Net Income|Clene Nanomedicine - Net Profit|PEPG - Net Profit|Jupiter Neurosciences Inc (JUNS) - Company Net Income|RLMD (Relmada Therapeutics Inc) - Company Net Income|Company Net Income Annovis Bio Corp|Grace Tx (GRCE) - Net Financial Result|Net Income AIFF (Firefly Neuroscience, Inc)|anewmeds.com - Company Profit|Net Profit NRSN (NeuroSense Therapeutics Ltd.)|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Company Net Income|MTVA - Company Net Income|NRXS (NeurAxis Inc) - Company Profit|HSDT: Net Profit|Company Net Income Passage Bio (PASG)|Company Net Income Neuphoria Therapeutics, Inc.|Company Profit NERV (Minerva Neurosciences Inc)|Net Profit ATHA|ADXN - Company Net Income|Alzamend Neuro - Net Income|Net Profit Cyclerion Therapeutics Inc. CYCN|PTIX - Company Net Income|Final Profit KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Company Net Income|Company Net Income Avenue Therapeutics Inc (ATXI)|Net Income BCLI|Company Profit CARA (caratherapeutics.com)|Net Profit CHRO|ELYM - Company Net Income|Company Net Income Intra-Cellular Therapies, Inc. ITCI|LBPH: Company Profit|MRNS - Company Net Income|Company Net Income nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|Company Profit SAGE|Net Income SNPX|TRVN: Final Profit|Company Net Income Vigil Neuroscience (VIGL)|WENA: Profit After Tax|Net Profit CERE (Cerevel Therapeutics, Inc.)